We only have this paper's title and publication details.
Read it at the sourcePlasma BART8-3p is a promising biomarker for the detection and prognosis of NPC.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: